` 241 (Alibaba Health Information Technology Ltd) vs Hang Seng (Hong Kong) Comparison - Alpha Spread

241
vs
Hang Seng (Hong Kong)

Over the past 12 months, has underperformed Hang Seng (Hong Kong), delivering a return of 27% compared to the Hang Seng (Hong Kong)'s 29% growth.

Stocks Performance
241 vs Hang Seng (Hong Kong)

Loading
241
Hang Seng (Hong Kong)
Add Stock
www.alphaspread.com

Performance Gap
241 vs Hang Seng (Hong Kong)

Loading

Over the past 12 months, has underperformed Hang Seng (Hong Kong) by 2.29%.

241
Hang Seng (Hong Kong)
Difference
www.alphaspread.com

Performance By Year
241 vs Hang Seng (Hong Kong)

Loading
241
Hang Seng (Hong Kong)
Add Stock

Competitors Performance
Alibaba Health Information Technology Ltd vs Peers

Hang Seng (Hong Kong)
241
AMZN
BABA
PDD
MELI
Add Stock

Alibaba Health Information Technology Ltd
Glance View

Market Cap
73.2B HKD
Industry
Retail

Alibaba Health Information Technology Ltd., often referred to as Alibaba Health, is a pioneering force in the rapidly evolving realm of digital healthcare. As the healthcare arm of the Alibaba conglomerate, it capitalizes on the group's formidable tech expertise and e-commerce prowess to streamline health services. Its operations stretch across several domains, from pharmaceutical retail to medical services. One of the company's key strengths lies in its online pharmacy platform. Partnering with various pharmaceutical brands, Alibaba Health provides an extensive digital marketplace for medications, health supplements, and medical devices. This platform not only simplifies access for consumers but also integrates data analytics to manage supply chains efficiently, ensuring timely availability of products. Beyond its e-commerce foundation, Alibaba Health is also cultivating a robust digital health ecosystem. It offers telemedicine services where users can consult healthcare professionals via online platforms, a feature that gained significant traction during pandemic-related lockdowns. Moreover, the company dives deep into health management technologies, utilizing artificial intelligence to develop personalized health plans and digital tools for patient monitoring. By harnessing big data, Alibaba Health assists in forming public health decisions and improving patient outcomes. Revenues stream from not just product sales, but also subscription fees and partnerships with health providers and governments alike, positioning the company as a pivotal player in China's push towards a more integrated and efficient healthcare system.

Intrinsic Value
3.05 HKD
Overvaluation 33%
Intrinsic Value
Price
A
Back to Top